Protein folding and misfolding, endoplasmic reticulum stress in neurodegenerative diseases: In trace of novel drug targets

Current Protein and Peptide Science

Volumn 17, Issue 2, 2016, Pages 169-182

  Penke, Botond ^a   Bogár, Ferenc ^a   Fülöp, Lívia ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Drug design; IDB; Misfolding; Protein folding; Refolding chaperones; Unfolded protein response

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; HEAT SHOCK PROTEIN; INTRINSICALLY DISORDERED PROTEIN; PHOSPHATIDYLSERINE SYNTHASE; SIGMA 1 OPIATE RECEPTOR; STRESS ACTIVATED PROTEIN KINASE; TAU PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; AMYLOID PRECURSOR PROTEIN;

ALZHEIMER DISEASE; AMNESIA; ARTICLE; CENTRAL NERVOUS SYSTEM FUNCTION; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DEMENTIA; ENDOPLASMIC RETICULUM STRESS; HOMEOSTASIS; HUMAN; HUNTINGTON CHOREA; METABOLIC REGULATION; MITOCHONDRIAL DYNAMICS; PARKINSON DISEASE; PATHOGENESIS; PRION DISEASE; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN MISFOLDING; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; UNFOLDED PROTEIN RESPONSE; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; DRUG DELIVERY SYSTEM; METABOLISM; MITOCHONDRION; MOLECULAR GENETICS; PATHOLOGY;

AMINO ACID SEQUENCE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; DRUG DELIVERY SYSTEMS; ENDOPLASMIC RETICULUM STRESS; HUMANS; MITOCHONDRIA; MOLECULAR SEQUENCE DATA; NEURODEGENERATIVE DISEASES; PROTEIN FOLDING;

EID: 84958979045     PISSN: 13892037     EISSN: 18755550     Source Type: Journal    
DOI: 10.2174/1389203716666151102104653     Document Type: Article

References (183)

1. Alzheimer's Disease International. World Alzheimer Report 2012: Overcoming the stigma of dementia: http: //www. alz. co. uk/research/WorldAlzheimerReport2012. pdf(Ac cessed March 1, 2015).
2. O'Brien, R. J.; Wong, P. C. Amyloid Precursor Protein Processing and Alzheimer's Disease. In Annual Review of Neuroscience, Vol 34, Hyman, S. E.; Jessell, T. M.; Shatz, C. J.; Stevens, C. F.; Zoghbi, H. Y., Eds. 2011; Vol. 34, pp 185-204.
3. Pavlov, P. F.; Wiehager, B.; Sakai, J.; Frykman, S.; Behbahani, H.; Winblad, B.; Ankarcrona, M. Mitochondrial gamma-secretase participates in the metabolism of mitochondria-associated amyloid precursor protein. FASEB J., 2011, 25(1), 78-88.
4. Epis, R.; Marcello, E.; Gardoni, F.; Di Luca, M. Alpha, beta-and gamma-secretases in Alzheimer's disease. Front. Biosci., Scholar Ed., 2011, 4, 1126-1150.
5. Mattson, M. P. Pathways towards and away from Alzheimer's disease. Nature, 2004, 430(7000), 631-639.
6. Hardy, J.; Selkoe, D. J. Medicine-The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science, 2002, 297(5580), 353-356.
7. Trojanowski, J. Q.; Lee, V. M. Y. Phosphorylation of paired helical filament tau in Alzheimer's disease neurofibrillary lesions: Focusing on phosphatases. FASEB J., 1995, 9(15), 1570-1576.
8. Swerdlow, R. H. Brain aging, Alzheimer's disease, and mitochondria. Biochim. Biophys. Acta, Mol. Basis Dis., 2011, 1812(12), 1630-1639.
9. Swerdlow, R. H.; Burns, J. M.; Khan, S. M. The Alzheimer's disease mitochondrial cascade hypothesis: Progress and perspectives. Biochim. Biophys. Acta, Mol. Basis Dis., 2014, 1842(8), 1219-1231.
10. LaFerla, F. M.; Green, K. N.; Oddo, S. Intracellular amyloid-beta in Alzheimer's disease. Nat. Rev. Neurosci., 2007, 8(7), 499-509.
11. Tampellini, D.; Capetillo-Zarate, E.; Dumont, M.; Huang, Z. Y.; Yu, F. M.; Lin, M. T.; Gouras, G. K. Effects of Synaptic Modulation on beta-Amyloid, Synaptophysin, and Memory Performance in Alzheimer's Disease Transgenic Mice. J. Neurosci., 2010, 30(43), 14299-14304.
12. Blair, J. A.; Siedlak, S. L.; Wolfram, J. A.; Nunomura, A.; Castellani, R. J.; Ferreira, S. T.; Klein, W. L.; Wang, Y.; Casadesus, G.; Smith, M. A.; Perry, G.; Zhu, X. W.; Lee, H. G. Accumulation of Intraneuronal Amyloid-beta is Common in Normal Brain. Curr. Alzheimer. Res., 2014, 11(4), 317-324.
13. Katayama, T.; Imaizumi, K.; Manabe, T.; Hitomi, J.; Kudo, T.; Tohyama, M. Induction of neuronal death by ER stress in Alzheimer's disease. J. Chem. Neuroanat., 2004, 28(1-2), 67-78.
14. Unterberger, U.; Hoftberger, R.; Gelpi, E.; Flicker, H.; Budka, H.; Voigtlander, T. Endoplasmic reticulum stress features are prominent in Alzheimer disease but not in prion diseases in vivo. J. Neuropathol. Exp. Neurol., 2006, 65(4), 348-357.
15. Kim, I.; Xu, W. J.; Reed, J. C. Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities. Nat. Rev. Drug Discovery, 2008, 7(12), 1013-1030.
16. Soejima, N.; Ohyagi, Y.; Nakamura, N.; Himeno, E.; Iinuma, K. M.; Sakae, N.; Yamasaki, R.; Tabira, T.; Murakami, K.; Irie, K.; Kinoshita, N.; LaFerla, F. M.; Kiyohara, Y.; Iwaki, T.; Kira, J. I. Intracellular Accumulation of Toxic Turn Amyloid-beta is Associated with Endoplasmic Reticulum Stress in Alzheimer's Disease. Curr. Alzheimer. Res., 2013, 10(1), 11-20.
17. Li, J.-Q.; Yu, J.-T.; Jiang, T.; Tan, L. Endoplasmic Reticulum Dysfunction in Alzheimer's Disease. Mol. Neurobiol., 2014, 1-13.
18. Roussel, B. D.; Kruppa, A. J.; Miranda, E.; Crowther, D. C.; Lomas, D. A.; Marciniak, S. J. Endoplasmic reticulum dysfunction in neurological disease. Lancet Neurol., 2013, 12(1), 105-118.
19. Hetz, C.; Mollereau, B. Disturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases. Nat. Rev. Neurosci., 2014, 15(4), 233-249.
20. Alberdi, E.; Wyssenbach, A.; Alberdi, M.; Sanchez-Gomez, M. V.; Cavaliere, F.; Rodriguez, J. J.; Verkhratsky, A.; Matute, C. Ca2+-dependent endoplasmic reticulum stress correlates with astrogliosis in oligomeric amyloid-treated astrocytes and in a model of Alzheimer's disease. Aging Cell, 2013, 12(2), 292-302.
21. Endres, K.; Reinhardt, S. ER-stress in Alzheimer's disease: turning the scale? Am. J. Neurodeg. Dis., 2013, 2(4), 247.
22. Placido, A. I.; Pereira, C. M. F.; Duarte, A. I.; Candeias, E.; Correia, S. C.; Santos, R. X.; Carvalho, C.; Cardoso, S.; Oliveira, C. R.; Moreira, P. I. The role of endoplasmic reticulum in amyloid precursor protein processing and trafficking: Implications for Alzheimer's disease. Biochim. Biophys. Acta, Mol. Basis Dis., 2014, 1842(9), 1444-1453.
23. Selfridge, J. E.; E, L. Z.; Lu, J. H.; Swerdlow, R. H. Role of mitochondrial homeostasis and dynamics in Alzheimer's disease. Neurobiol. Dis., 2013, 51, 3-12.
24. Bernales, S.; Soto, M. M.; McCullagh, E. Unfolded protein stress in the endoplasmic reticulum and mitochondria: a role in neurodegeneration. Front. Aging Neurosci., 2012, 4, 5.
25. Area-Gomez, E.; Castillo, M. D. L.; Tambini, M. D.; Guardia-Laguarta, C.; de Groof, A. J. C.; Madra, M.; Ikenouchi, J.; Umeda, M.; Bird, T. D.; Sturley, S. L.; Schon, E. A. Upregulated function of mitochondria-associated ER membranes in Alzheimer disease. EMBO J., 2012, 31(21), 4106-4123.
26. Hedskog, L.; Pinho, C. M.; Filadi, R.; Ronnback, A.; Hertwig, L.; Wiehager, B.; Larssen, P.; Gellhaar, S.; Sandebring, A.; Westerlund, M.; Graff, C.; Winblad, B.; Galter, D.; Behbahani, H.; Pizzo, P.; Glaser, E.; Ankarcrona, M. Modulation of the endoplasmic reticulum-mitochondria interface in Alzheimer's disease and related models. Proc. Natl. Acad. Sci. U. S. A., 2013, 110(19), 7916-7921.
27. Schon, E. A.; Area-Gomez, E. Mitochondria-associated ER membranes in Alzheimer disease. Mol. Cell. Neurosci., 2013, 55, 26-36.
28. Stoica, R.; De Vos, K. J.; Paillusson, S.; Mueller, S.; Sancho, R. M.; Lau, K. F.; Vizcay-Barrena, G.; Lin, W. L.; Xu, Y. F.; Lewis, J.; Dickson, D. W.; Petrucelli, L.; Mitchell, J. C.; Shaw, C. E.; Miller, C. C. J. ER-mitochondria associations are regulated by the VAPBPTPIP51 interaction and are disrupted by ALS/FTD-associated TDP-43. Nat. Commun., 2014, 5, 3996.
29. Uversky, V. N. Targeting intrinsically disordered proteins in neurodegenerative and protein dysfunction diseases: another illustration of the D-2 concept. Expert Rev. Proteomics, 2010, 7(4), 543-564.
30. Colby, D. W.; Prusiner, S. B. Prions. Cold Spring Harb. Perspect. Biol., 2011, 3(1), a006833.
31. Lundblad, M.; Decressac, M.; Mattsson, B.; Bjorklund, A. Impaired neurotransmission caused by overexpression of alphasynuclein in nigral dopamine neurons. Proc. Natl. Acad. Sci. U. S. A., 2012, 109(9), 3213-3219.
32. Breydo, L.; Wu, J. W.; Uversky, V. N. alpha-Synuclein misfolding and Parkinson's disease. Biochim. Biophys. Acta, Mol. Basis Dis., 2012, 1822(2), 261-285.
33. Kovari, E.; Horvath, J.; Bouras, C. Neuropathology of Lewy body disorders. Brain Res. Bull., 2009, 80(4-5), 203-210.
34. Bosco, D. A.; LaVoie, M. J.; Petsko, G. A.; Ringe, D. Proteostasis and Movement Disorders: Parkinson's Disease and Amyotrophic Lateral Sclerosis. Cold Spring Harb. Perspect. Biol., 2011, 3(10), a007500.
35. Sassone, J.; Colciago, C.; Cislaghi, G.; Silani, V.; Ciammola, A. Huntington's disease: The current state of research with peripheral tissues. Exp. Neurol., 2009, 219(2), 385-397.
36. Iqbal, K.; Alonso, A. D. C.; Chen, S.; Chohan, M. O.; El-Akkad, E.; Gong, C. X.; Khatoon, S.; Li, B.; Liu, F.; Rahman, A.; Tanimukai, H.; Grundke-Iqbal, I. Tau pathology in Alzheimer disease and other tauopathies. Biochim. Biophys. Acta, Mol. Basis Dis., 2005, 1739(2-3), 198-210.
37. Menendez, M. Down syndrome, Alzheimer's disease and seizures. Brain & Dev., 2005, 27(4), 246-252.
38. Hardy, J.; Allsop, D. Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol. Sci., 1991, 12, 383-388.
39. Hardy, J. The amyloid hypothesis for Alzheimer's disease: a critical reappraisal. J. Neurochem., 2009, 110(4), 1129-1134.
40. Golde, T. E.; Dickson, D.; Hutton, M. Filling the gaps in the Aβ cascade hypothesis of Alzheimer's disease. Curr. Alzheimer. Res., 2006, 3(5), 421-430.
41. Jonsson, T.; Atwal, J. K.; Steinberg, S.; Snaedal, J.; Jonsson, P. V.; Bjornsson, S.; Stefansson, H.; Sulem, P.; Gudbjartsson, D.; Maloney, J.; Hoyte, K.; Gustafson, A.; Liu, Y. C.; Lu, Y. M.; Bhangale, T.; Graham, R. R.; Huttenlocher, J.; Bjornsdottir, G.; Andreassen, O. A.; Jonsson, E. G.; Palotie, A.; Behrens, T. W.; Magnusson, O. T.; Kong, A.; Thorsteinsdottir, U.; Watts, R. J.; Stefansson, K. A mutation in APP protects against Alzheimer's disease and age-related cognitive decline. Nature, 2012, 488(7409), 96-99.
42. Selkoe, D. J.; Podlisny, M. B. Deciphering the genetic basis of Alzheimer's disease. Annu. Rev. Genomics Hum. Genet., 2002, 3, 67-99.
43. Kar, S.; Slowikowski, S. P. M.; Westaway, D.; Mount, H. T. J. Interactions between beta-amyloid and central cholinergic neurons: implications for Alzheimer's disease. J. Psychiatry Neurosci., 2004, 29(6), 427-441.
44. Nagele, R. G.; Wegiel, J.; Venkataraman, V.; Imaki, H.; Wang, K. C. Contribution of glial cells to the development of amyloid plaques in Alzheimer's disease. Neurobiol. Aging, 2004, 25(5), 663-674.
45. Tran, M. H.; Yamada, K.; Nabeshima, T. Amyloid beta-peptide induces cholinergic dysfunction and cognitive deficits: a minireview. Peptides, 2002, 23(7), 1271-1283.
46. Krafft, G. A.; Klein, W. L. ADDLs and the signaling web that leads to Alzheimer's disease. Neuropharmacology, 2010, 59(4-5), 230-242.
47. Schliebs, R.; Arendt, T. The cholinergic system in aging and neuronal degeneration. Behav. Brain Res., 2011, 221(2), 555-563.
48. Patel, A. N.; Jhamandas, J. H. Neuronal receptors as targets for the action of amyloid-beta protein(A beta) in the brain. Expert Rev. Mol. Med., 2012, 14, e2.
49. Thathiah, A.; De Strooper, B. The role of G protein-coupled receptors in the pathology of Alzheimer's disease. Nat. Rev. Neurosci., 2011, 12(2), 73-87.
50. Nath, S.; Agholme, L.; Kurudenkandy, F. R.; Granseth, B.; Marcusson, J.; Hallbeck, M. Spreading of Neurodegenerative Pathology via Neuron-to-Neuron Transmission of beta-Amyloid. J. Neurosci., 2012, 32(26), 8767-8777.
51. Friedrich, R. P.; Tepper, K.; Roznicke, R.; Soom, M.; Westermann, M.; Reymann, K.; Kaether, C.; Fandrich, M. Mechanism of amyloid plaque formation suggests an intracellular basis of A beta pathogenicity. Proc. Natl. Acad. Sci. U. S. A., 2010, 107(5), 1942-1947.
52. Gimenez-Llort, L.; Blazquez, G.; Canete, T.; Johansson, B.; Oddo, S.; Tobena, A.; LaFerla, F. M.; Fernandez-Teruel, A. Modeling behavioral and neuronal symptoms of Alzheimer's disease in mice: A role for intraneuronal amyloid. Neurosci. Biobehav. Rev., 2007, 31(1), 125-147.
53. Li, M.; Chen, L.; Lee, D. H. S.; Yu, L. C.; Zhang, Y. The role of intracellular amyloid beta in Alzheimer's disease. Prog. Neurobiol., 2007, 83(3), 131-139.
54. Gouras, G. K.; Tampellini, D.; Takahashi, R. H.; Capetillo-Zarate, E. Intraneuronal beta-amyloid accumulation and synapse pathology in Alzheimer's disease. Acta Neuropathol., 2010, 119(5), 523-541.
55. Bayer, T. A.; Wirths, O. Intracellular accumulation of amyloid-beta-a predictor for synaptic dysfunction and neuron loss in Alzheimer's disease. Front. Aging Neurosci., 2010, 2, 8.
56. Zhang, Y. Intracellular Amyloid β: A Modification to the Amyloid Hypothesis in Alzheimer's Disease. In Lipids and Cellular Membranes in Amyloid Diseases, Wiley-VCH Verlag GmbH & Co. KGaA: 2011; pp. 143-157.
57. Casas, C.; Sergeant, N.; Itier, J. M.; Blanchard, V.; Wirths, O.; van der Kolk, N.; Vingtdeux, V.; van de Steeg, E.; Ret, G.; Canton, T.; Drobecq, H.; Clark, A.; Bonici, B.; Delacourte, A.; Benavides, J.; Schmitz, C.; Tremp, G.; Bayer, T. A.; Benoit, P.; Pradier, L. Massive CA1/2 neuronal loss with intraneuronal and N-interminal truncated A beta(42) accumulation in a novel Alzheimer transgenic model. Am. J. Pathol., 2004, 165(4), 1289-1300.
58. Billings, L. M.; Oddo, S.; Green, K. N.; McGaugh, J. L.; LaFerla, F. M. Intraneuronal A beta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron, 2005, 45(5), 675-688.
59. Tomiyama, T.; Matsuyama, S.; Iso, H.; Umeda, T.; Takuma, H.; Ohnishi, K.; Ishibashi, K.; Teraoka, R.; Sakama, N.; Yamashita, T.; Nishitsuji, K.; Ito, K.; Shimada, H.; Lambert, M. P.; Klein, W. L.; Mori, H. A Mouse Model of Amyloid beta Oligomers: Their Contribution to Synaptic Alteration, Abnormal Tau Phosphorylation, Glial Activation, and Neuronal Loss In Vivo. J. Neurosci., 2010, 30(14), 4845-4856.
60. Abramowski, D.; Rabe, S.; Upadhaya, A. R.; Reichwald, J.; Danner, S.; Staab, D.; Capetillo-Zarate, E.; Yamaguchi, H.; Saido, T. C.; Wiederhold, K. H.; Thal, D. R.; Staufenbiel, M. Transgenic Expression of Intraneuronal A beta(42) But Not A beta(40) Leads to Cellular A beta Lesions, Degeneration, and Functional Impairment without Typical Alzheimer's Disease Pathology. J. Neurosci., 2012, 32(4), 1273-1283.
61. Iqbal, K.; Liu, F.; Gong, C. X.; Alonso, A. D.; Grundke-Iqbal, I. Mechanisms of tau-induced neurodegeneration. Acta Neuropathol., 2009, 118(1), 53-69.
62. Takashima, A. Hyperphosphorylated tau is a cause of neuronal dysfunction in tauopathy. J. Alzheimer's Dis., 2008, 14(4), 371-375.
63. Martin, L.; Latypova, X.; Terro, F. Post-translational modifications of tau protein: Implications for Alzheimer's disease. Neurochem. Int., 2011, 58(4), 458-471.
64. Braak, H.; Braak, E. Staging of Alzheimer's-disease-related neurofibrillary changes. Neurobiol. Aging, 1995, 16(3), 271-278.
65. Small, S. A.; Duff, K. Linking A beta and Tau in Late-Onset Alzheimer's Disease: A Dual Pathway Hypothesis. Neuron, 2008, 60(4), 534-542.
66. Shipton, O. A.; Leitz, J. R.; Dworzak, J.; Acton, C. E. J.; Tunbridge, E. M.; Denk, F.; Dawson, H. N.; Vitek, M. P.; Wade-Martins, R.; Paulsen, O.; Vargas-Caballero, M. Tau Protein Is Required for Amyloid beta-Induced Impairment of Hippocampal Long-Term Potentiation. J. Neurosci., 2011, 31(5), 1688-1692.
67. Reifert, J.; Hartung-Cranston, D.; Feinstein, S. C. Amyloid beta-Mediated Cell Death of Cultured Hippocampal Neurons Reveals Extensive Tau Fragmentation without Increased Full-length Tau Phosphorylation. J Biol Chem, 2011, 286(23), 20797-20811.
68. Jaworski, T.; Kugler, S.; Van Leuven, F. Modeling of tau-mediated synaptic and neuronal degeneration in Alzheimer's disease. Int. J. Alzheimer's Dis., 2010, 2010.
69. Ittner, L. M.; Gotz, J. Amyloid-beta and tau-a toxic pas de deux in Alzheimer's disease. Nat. Rev. Neurosci., 2011, 12(2), 67-72.
70. Auluck, P. K.; Caraveo, G.; Lindquist, S. alpha-Synuclein: Membrane Interactions and Toxicity in Parkinson's Disease. In Annual Review of Cell and Developmental Biology, Vol 26, Schekman, R.; Goldstein, L.; Lehmann, R., Eds. 2010; Vol. 26, pp 211-233.
71. Reinhard, C.; Hebert, S. S.; De Strooper, B. The amyloid-beta precursor protein: integrating structure with biological function. EMBO J., 2005, 24(23), 3996-4006.
72. Thinakaran, G.; Koo, E. H. Amyloid Precursor Protein Trafficking, Processing, and Function. J Biol Chem, 2008, 283(44), 29615-29619.
73. Leyssen, M.; Ayaz, D.; Hebert, S. S.; Reeve, S.; De Strooper, B.; Hassan, B. A. Amyloid precursor protein promotes postdevelopmental neurite arborization in the Drosophila brain. EMBO J., 2005, 24(16), 2944-2955.
74. Roch, J. M.; Masliah, E.; Rochlevecq, A. C.; Sundsmo, M. P.; Otero, D. A. C.; Veinbergs, I.; Saitoh, T. Increase of synaptic density and memory retention by a peptide representing the trophic domain of the amyloid beta/A4 protein-precursor. Proc. Natl. Acad. Sci. U. S. A., 1994, 91(16), 7450-7454.
75. Turner, P. R.; O'Connor, K.; Tate, W. P.; Abraham, W. C. Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory. Prog. Neurobiol., 2003, 70(1), 1-32.
76. Lee, K. J.; Moussa, C. E. H.; Lee, Y.; Sung, Y.; Howell, B. W.; Turner, R. S.; Pak, D. T. S.; Hoe, H. S. Beta amyloid-independent role of amyloid precursor protein in generation and maintenance of dendritic spines. Neuroscience, 2010, 169(1), 344-356.
77. Randall, A. D.; Witton, J.; Booth, C.; Hynes-Allen, A.; Brown, J. T. The functional neurophysiology of the amyloid precursor protein(APP) processing pathway. Neuropharmacology, 2010, 59(4-5), 243-267.
78. Lammich, S.; Kojro, E.; Postina, R.; Gilbert, S.; Pfeiffer, R.; Jasionowski, M.; Haass, C.; Fahrenholz, F. Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. Proc. Natl. Acad. Sci. U. S. A., 1999, 96(7), 3922-3927.
79. Lai, A.; Sisodia, S. S.; Trowbridge, I. S. Characterization of sorting signals in the beta-amyloid precursor protein cytoplasmic domain. J Biol Chem, 1995, 270(8), 3565-3573.
80. Perez, R. G.; Soriano, S.; Hayes, J. D.; Ostaszewski, B.; Xia, W. M.; Selkoe, D. J.; Chen, X. H.; Stokin, G. B.; Koo, E. H. Mutagenesis identifies new signals for beta-amyloid precursor protein endocytosis, turnover, and the generation of secreted fragments, including A beta 42. J. Biol. Chem., 1999, 274(27), 18851-18856.
81. Grimm, H. S.; Beher, D.; Lichtenthaler, S. F.; Shearman, M. S.; Beyreuther, K.; Hartmann, T. gamma-secretase cleavage site specificity differs for intracellular and secretory amyloid beta. J. Biol. Chem., 2003, 278(15), 13077-13085.
82. Choy, R. W. Y.; Cheng, Z. L.; Schekman, R. Amyloid precursor protein(APP) traffics from the cell surface via endosomes for amyloid beta(A beta) production in the trans-Golgi network. Proc. Natl. Acad. Sci. U. S. A., 2012, 109(30), E2077-E2082.
83. Tam, J. H. K.; Seah, C.; Pasternak, S. H. The Amyloid Precursor Protein is rapidly transported from the Golgi apparatus to the lysosome and where it is processed into beta-amyloid. Mol. Brain, 2014, 7.
84. Chyung, A. S. C.; Greenberg, B. D.; Cook, D. G.; Doms, R. W.; Lee, V. M. Y. Novel beta-secretase cleavage of beta-amyloid precursor protein in the endoplasmic reticulum intermediate compartment of NT2N cells. J. Cell Biol., 1997, 138(3), 671-680.
85. Shin, R. W.; Saido, T. C.; Maeda, M.; Kitamoto, T. Novel alphasecretase cleavage of Alzheimer's amyloid beta precursor protein in the endoplasmic reticulum of COS7 cells. Neurosci. Lett., 2005, 376(1), 14-19.
86. Vetrivel, K. S.; Thinakaran, G. Membrane rafts in Alzheimer's disease beta-amyloid production. Biochim. Biophys. Acta, Mol. Cell Biol. Lipids, 2010, 1801(8), 860-867.
87. Yoon, S. O.; Park, D. J.; Ryu, J. C.; Ozer, H. G.; Tep, C.; Shin, Y. J.; Lim, T. H.; Pastorino, L.; Kunwar, A. J.; Walton, J. C.; Nagahara, A. H.; Lu, K. P.; Nelson, R. J.; Tuszynski, M. H.; Huang, K. JNK3 Perpetuates Metabolic Stress Induced by A beta Peptides. Neuron, 2012, 75(5), 824-837.
88. Kondo, T.; Asai, M.; Tsukita, K.; Kutoku, Y.; Ohsawa, Y.; Sunada, Y.; Imamura, K.; Egawa, N.; Yahata, N.; Okita, K.; Takahashi, K.; Asaka, I.; Aoi, T.; Watanabe, A.; Watanabe, K.; Kadoya, C.; Nakano, R.; Watanabe, D.; Maruyama, K.; Hori, O.; Hibino, S.; Choshi, T.; Nakahata, T.; Hioki, H.; Kaneko, T.; Naitoh, M.; Yoshikawa, K.; Yamawaki, S.; Suzuki, S.; Hata, R.; Ueno, S.; Seki, T.; Kobayashi, K.; Toda, T.; Murakami, K.; Irie, K.; Klein, W. L.; Mori, H.; Asada, T.; Takahashi, R.; Iwata, N.; Yamanaka, S.; Inoue, H. Modeling Alzheimer's Disease with iPSCs Reveals Stress Phenotypes Associated with Intracellular A beta and Differential Drug Responsiveness. Cell Stem Cell, 2013, 12(4), 487-496.
89. Lai, C. S. W.; Preisler, J.; Baum, L.; Lee, D. H. S.; Ng, H. K.; Hugon, J.; So, K. F.; Chang, R. C. C. Low molecular weight A beta induces collapse of endoplasmic reticulum. Mol. Cell. Neurosci., 2009, 41(1), 32-43.
90. Winkler, E.; Kamp, F.; Scheuring, J.; Ebke, A.; Fukumori, A.; Steiner, H. Generation of Alzheimer Disease-associated Amyloid beta(42/43) Peptide by gamma-Secretase Can Be Inhibited Directly by Modulation of Membrane Thickness. J Biol Chem, 2012, 287(25), 21326-21334.
91. Burns, M. P.; Rebeck, G. W. Intracellular cholesterol homeostasis and amyloid precursor protein processing. Biochim. Biophys. Acta, Mol. Cell Biol. Lipids, 2010, 1801(8), 853-859.
92. Pearson, H. A.; Peers, C. Physiological roles for amyloid beta peptides. J. Physiol. (London, U. K.), 2006, 575(1), 5-10.
93. Hiltunen, M.; van Groen, T.; Jolkkonen, J. Functional Roles of Amyloid-beta Protein Precursor and Amyloid-beta Peptides: Evidence from Experimental Studies. J. Alzheimer's Dis., 2009, 18(2), 401-412.
94. Kuperstein, I.; Broersen, K.; Benilova, I.; Rozenski, J.; Jonekheere, W.; Debulpaep, M.; Vandersteen, A.; Segers-Nolten, I.; Van der Werf, K.; Subramaniam, V.; Braeken, D.; Callewaert, G.; Bartic, C.; D'Hooge, R.; Martins, I. C.; Rousseau, F.; Schymkowitz, J.; De Strooper, B. Neurotoxicity of Alzheimer's disease A beta peptides is induced by small changes in the A beta(42) to A beta(40) ratio. EMBO J., 2010, 29(19), 3408-3420.
95. Giuffrida, M. L.; Caraci, F.; De Bona, P.; Pappalardo, G.; Nicoletti, F.; Rizzarelli, E.; Copani, A. The Monomer State of Beta-Amyloid: Where the Alzheimer's Disease Protein Meets Physiology. Rev. Neurosci., 2010, 21(2), 83-93.
96. Sakono, M.; Zako, T. Amyloid oligomers: formation and toxicity of A beta oligomers. FEBS J., 2010, 277(6), 1348-1358.
97. Upadhaya, A. R.; Capetillo-Zarate, E.; Kosterin, I.; Abramowski, D.; Kumar, S.; Yamaguchi, H.; Walter, J.; Fandrich, M.; Staufenbiel, M.; Thal, D. R. Dispersible amyloid beta-protein oligomers, protofibrils, and fibrils represent diffusible but not soluble aggregates: their role in neurodegeneration in amyloid precursor protein(APP) transgenic mice. Neurobiol. Aging, 2012, 33(11), 2641-2660.
98. Jan, A.; Hartley, D. M.; Lashuel, H. A. Preparation and characterization of toxic A beta aggregates for structural and functional studies in Alzheimer's disease research. Nat. Protoc., 2010, 5(6), 1186-1209.
99. Benilova, I.; Karran, E.; De Strooper, B. The toxic A beta oligomer and Alzheimer's disease: an emperor in need of clothes. Nature Neurosci., 2012, 15(3), 349-357.
100. Brouillette, J.; Caillierez, R.; Zommer, N.; Alves-Pires, C.; Benilova, I.; Blum, D.; De Strooper, B.; Buee, L. Neurotoxicity and Memory Deficits Induced by Soluble Low-Molecular-Weight Amyloid-beta(1-42) Oligomers Are Revealed In Vivo by Using a Novel Animal Model. J. Neurosci., 2012, 32(23), 7852-7861.
101. Dobson, C. M. The structural basis of protein folding and its links with human disease. Philos. Trans. R. Soc., B, 2001, 356(1406), 133-145.
102. Dobson, C. M. Protein folding and misfolding. Nature, 2003, 426(6968), 884-890.
103. Goloubinoff, P. Recent and Future Grand Challenges In Protein folding, Misfolding and Degradation. Front. Mol. Biosci., 2014, 1, 1.
104. Nagai, Y.; Inui, T.; Popiel, H. A.; Fujikake, N.; Hasegawa, K.; Urade, Y.; Goto, Y.; Naiki, H.; Toda, T. A toxic monomeric conformer of the polyglutamine protein. Nat. Struct. Mol. Biol., 2007, 14(4), 332-340.
105. Sherzai, A.; Edland, S. D.; Masliah, E.; Hansen, L.; Pizzo, D. P.; Corey-Bloom, J. Spongiform Change in Dementia With Lewy Bodies and Alzheimer Disease. Alzheimer Dis. Assoc. Disord., 2013, 27(2), 157-161.
106. Uversky, V. N. Mysterious oligomerization of the amyloidogenic proteins. FEBS J., 2010, 277(14), 2940-2953.
107. Turoverov, K. K.; Kuznetsova, I. M.; Uversky, V. N. The protein kingdom extended: Ordered and intrinsically disordered proteins, their folding, supramolecular complex formation, and aggregation. Prog. Biophys. Mol. Biol., 2010, 102(2-3), 73-84.
108. Uversky, V. N. Intrinsically disordered proteins and novel strategies for drug discovery. Expert Opin. Drug Discovery, 2012, 7(6), 475-488.
109. Bernstein, F. C.; Koetzle, T. F.; Williams, G. J. B.; Meyer Jr, E. F.; Brice, M. D.; Rodgers, J. R.; Kennard, O.; Shimanouchi, T.; Tasumi, M. The Protein Data Bank: A Computer-based Archival File For Macromolecular Structures. J. Mol. Biol., 1977, 112(3), 535-542.
110. Habchi, J.; Tompa, P.; Longhi, S.; Uversky, V. N. Introducing Protein Intrinsic Disorder. Chem. Rev., 2014, 114(13), 6561-6588.
111. Uversky, V. N. The triple power of D-3: Protein intrinsic disorder in degenerative diseases. Front. Biosci., Landmark Ed., 2014, 19, 181-258.
112. Griffith, J. S. Self-replication and scrapie. Nature, 1967, 215(5105), 1043.
113. Prusiner, S. B. Some speculations about prions, amyloid, and Alzheimer's-disease. N. Engl. J. Med., 1984, 310(10), 661-663.
114. Nussbaum, J. M.; Schilling, S.; Cynis, H.; Silva, A.; Swanson, E.; Wangsanut, T.; Tayler, K.; Wiltgen, B.; Hatami, A.; Ronicke, R.; Reymann, K.; Hutter-Paier, B.; Alexandru, A.; Jagla, W.; Graubner, S.; Glabe, C. G.; Demuth, H. U.; Bloom, G. S. Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-beta. Nature, 2012, 485(7400), 651-655.
115. Eisele, Y. S.; Bolmont, T.; Heikenwalder, M.; Langer, F.; Jacobson, L. H.; Yan, Z. X.; Roth, K.; Aguzzi, A.; Staufenbiel, M.; Walker, L. C.; Jucker, M. Induction of cerebral beta-amyloidosis: Intracerebral versus systemic A beta inoculation. Proc. Natl. Acad. Sci. U. S. A., 2009, 106(31), 12926-12931.
116. Eisele, Y. S.; Obermuller, U.; Heilbronner, G.; Baumann, F.; Kaeser, S. A.; Wolburg, H.; Walker, L. C.; Staufenbiel, M.; Heikenwalder, M.; Jucker, M. Peripherally Applied A beta-Containing Inoculates Induce Cerebral beta-Amyloidosis. Science, 2010, 330(6006), 980-982.
117. Jucker, M.; Walker, L. C. Pathogenic Protein Seeding in Alzheimer Disease and Other Neurodegenerative Disorders. Ann. Neurol., 2011, 70(4), 532-540.
118. Stohr, J.; Watts, J. C.; Mensinger, Z. L.; Oehler, A.; Grillo, S. K.; DeArmond, S. J.; Prusiner, S. B.; Giles, K. Purified and synthetic Alzheimer's amyloid beta(A beta) prions. Proc. Natl. Acad. Sci. U. S. A., 2012, 109(27), 11025-11030.
119. Auer, S.; Dobson, C. M.; Vendruscolo, M.; Maritan, A. Self-Templated Nucleation in Peptide and Protein Aggregation. Phys. Rev. Lett., 2008, 101(25), 258101.
120. Polymenidou, M.; Cleveland, D. W. Prion-like spread of protein aggregates in neurodegeneration. J. Exp. Med., 2012, 209(5), 889-893.
121. Aguzzi, A.; Rajendran, L. The Transcellular Spread of Cytosolic Amyloids, Prions, and Prionoids. Neuron, 2009, 64(6), 783-790.
122. Aguzzi, A.; Falsig, J. PERSPECTIVE Prion propagation, toxicity and degradation. Nature Neurosci., 2012, 15(7), 936-939.
123. Soto, C.; Saborio, G. P.; Anderes, L. Cyclic amplification of protein misfolding: application to prion-related disorders and beyond. Trends Neurosci., 2002, 25(8), 390-394.
124. Saa, P.; Castilla, J.; Soto, C. Ultra-efficient replication of infectious prions by automated protein misfolding cyclic amplification. J Biol Chem, 2006, 281(46), 35245-35252.
125. Murayama, Y.; Yoshioka, M.; Yokoyama, T.; Iwamaru, Y.; Imamura, M.; Masujin, K.; Yoshiba, S.; Mohri, S. Efficient in vitro amplification of a mouse-adapted scrapie prion protein. Neurosci. Lett., 2007, 413(3), 270-273.
126. Gonzalez-Montalban, N.; Makarava, N.; Ostapchenko, V. G.; Savtchenk, R.; Alexeeva, I.; Rohwer, R. G.; Baskakov, I. V. Highly Efficient Protein Misfolding Cyclic Amplification. PLoS Pathog., 2011, 7(2), e1001277.
127. Moreno-Gonzalez, I.; Soto, C. Misfolded protein aggregates: Mechanisms, structures and potential for disease transmission. Semin. Cell Dev. Biol., 2011, 22(5), 482-487.
128. Soto, C.; Estrada, L.; Castilla, J. Amyloids, prions and the inherent infectious nature of misfolded protein aggregates. Trends Biochem. Sci., 2006, 31(3), 150-155.
129. Brundin, P.; Melki, R.; Kopito, R. Prion-like transmission of protein aggregates in neurodegenerative diseases. Nat. Rev. Mol. Cell Biol., 2010, 11(4), 301-307.
130. Clavaguera, F.; Bolmont, T.; Crowther, R. A.; Abramowski, D.; Frank, S.; Probst, A.; Fraser, G.; Stalder, A. K.; Beibel, M.; Staufenbiel, M.; Jucker, M.; Goedert, M.; Tolnay, M. Transmission and spreading of tauopathy in transgenic mouse brain. Nat. Cell Biol., 2009, 11(7), 909-U325.
131. Frost, B.; Jacks, R. L.; Diamond, M. I. Propagation of Tau Misfolding from the Outside to the Inside of a Cell. J Biol Chem, 2009, 284(19), 12845-12852.
132. Novak, P.; Prcina, M.; Kontsekova, E. Tauons and Prions: Infamous Cousins? J. Alzheimer's Dis., 2011, 26(3), 413-430.
133. Liu, L.; Drouet, V.; Wu, J. W.; Witter, M. P.; Small, S. A.; Clelland, C.; Duff, K. Trans-Synaptic Spread of Tau Pathology In Vivo. Plos One, 2012, 7(2), e31302.
134. de Calignon, A.; Polydoro, M.; Suarez-Calvet, M.; William, C.; Adamowicz, D. H.; Kopeikina, K. J.; Pitstick, R.; Sahara, N.; Ashe, K. H.; Carlson, G. A.; Spires-Jones, T. L.; Hyman, B. T. Propagation of Tau Pathology in a Model of Early Alzheimer's Disease. Neuron, 2012, 73(4), 685-697.
135. Hall, G. F.; Patuto, B. A. Is tau ready for admission to the prion club? Prion, 2012, 6(3), 223-233.
136. Saman, S.; Kim, W.; Raya, M.; Visnick, Y.; Miro, S.; Jackson, B.; McKee, A. C.; Alvarez, V. E.; Lee, N. C. Y.; Hall, G. F. Exosome associated Tau Is Secreted in Tauopathy Models and Is Selectively Phosphorylated in Cerebrospinal Fluid in Early Alzheimer Disease. J Biol Chem, 2012, 287(6), 3842-3849.
137. Kanouchi, T.; Ohkubo, T.; Yokota, T. Can regional spreading of amyotrophic lateral sclerosis motor symptoms be explained by prion-like propagation? J. Neurol. Psychiatry, 2012, 83(7), 739-745.
138. Luk, K. C.; Kehm, V. M.; Zhang, B.; O'Brien, P.; Trojanowski, J. Q.; Lee, V. M. Y. Intracerebral inoculation of pathological alphasynuclein initiates a rapidly progressive neurodegenerative alphasynucleinopathy in mice. J. Exp. Med., 2012, 209(5), 975-986.
139. Ren, P. H.; Lauckner, J. E.; Kachirskaia, I.; Heuser, J. E.; Melki, R.; Kopito, R. R. Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates. Nat. Cell Biol., 2009, 11(2), 219-U232.
140. Chen, B. A.; Morales, R.; Barria, M. A.; Soto, C. Estimating prion concentration in fluids and tissues by quantitative PMCA. Nat. Methods, 2010, 7(7), 519-U47.
141. Hoshino, T.; Nakaya, T.; Araki, W.; Suzuki, K.; Suzuki, T.; Mizushima, T. Endoplasmic reticulum chaperones inhibit the production of amyloid-beta peptides. Biochem. J., 2007, 402, 581-589.
142. Lee, C.; Ferguson, M.; Chen, L. B. Construction of the endoplasmic-reticulum. J. Cell Biol., 1989, 109(5), 2045-2055.
143. Bravo, R.; Parra, V.; Gatica, D.; Rodriguez, A. E.; Torrealba, N.; Paredes, F.; Wang, Z. V.; Zorzano, A.; Hill, J. A.; Jaimovich, E.; Quest, A. F. G.; Lavandero, S. Endoplasmic Reticulum and the Unfolded Protein Response: Dynamics and Metabolic Integration. In International Review of Cell and Molecular Biology, Vol 301, Jeon, K. W., Ed. 2013; Vol. 301, pp 215-290.
144. Gidalevitz, T.; Stevens, F.; Argon, Y. Orchestration of secretory protein folding by ER chaperones. Biochim. Biophys. Acta, Mol. Cell Res., 2013, 1833(11), 2410-2424.
145. Jansen, G.; Maattanen, P.; Denisov, A. Y.; Scarffe, L.; Schade, B.; Balghi, H.; Dejgaard, K.; Chen, L. Y.; Muller, W. J.; Gehring, K.; Thomas, D. Y. An Interaction Map of Endoplasmic Reticulum Chaperones and Foldases. Mol. Cell. Proteomics, 2012, 11(9), 710-723.
146. Maity, S.; Basak, T.; Bhat, A.; Bhasin, N.; Ghosh, A.; Chakraborty, K.; Sengupta, S. Cross-compartment proteostasis regulation during redox imbalance induced ER stress. Proteomics, 2014, 14(15), 1724-1736.
147. Hetz, C. The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat. Rev. Mol. Cell Biol., 2012, 13(2), 89-102.
148. Pereira, C. M. Crosstalk between endoplasmic reticulum stress and protein misfolding in neurodegenerative diseases. ISRN Cell Biol., 2013, 2013, 1-22.
149. Sitia, R.; Braakman, I. Quality control in the endoplasmic reticulum protein factory. Nature, 2003, 426(6968), 891-894.
150. Meusser, B.; Hirsch, C.; Jarosch, E.; Sommer, T. ERAD: the long road to destruction. Nat. Cell Biol., 2005, 7(8), 766-772.
151. Zhao, L. H.; Ackerman, S. L. Endoplasmic reticulum stress in health and disease. Curr. Opin. Cell Biol., 2006, 18(4), 444-452.
152. Woehlbier, U.; Hetz, C. Modulating stress responses by the UPRosome: A matter of life and death. Trends Biochem. Sci., 2011, 36(6), 329-337.
153. Badiola, N.; Penas, C.; Minano-Molina, A.; Barneda-Zahonero, B.; Fado, R.; Sanchez-Opazo, G.; Comella, J. X.; Sabria, J.; Zhu, C.; Blomgren, K.; Casas, C.; Rodriguez-Alvarez, J. Induction of ER stress in response to oxygen-glucose deprivation of cortical cultures involves the activation of the PERK and IRE-1 pathways and of caspase-12. Cell Death Dis., 2011, 2, e149.
154. Han, J.; Backa, S. H.; Hur, J.; Lin, Y. H.; Gildersleeve, R.; Shan, J. X.; Yuan, C. L.; Krokowski, D.; Wang, S. Y.; Hatzoglou, M.; Kilberg, M. S.; Sartor, M. A.; Kaufman, R. J. ER-stress-induced transcriptional regulation increases protein synthesis leading to cell death. Nat. Cell Biol., 2013, 15(5), 481-+.
155. Urra, H.; Dufey, E.; Lisbona, F.; Rojas-Rivera, D.; Hetz, C. When ER stress reaches a dead end. Biochim. Biophys. Acta, Mol. Cell Res., 2013, 1833(12), 3507-3517.
156. Safra, M.; Ben-Hamo, S.; Kenyon, C.; Henis-Korenblit, S. The ire-1 ER stress-response pathway is required for normal secretoryprotein metabolism in C. elegans. J. Cell Sci., 2013, 126(18), 4136-4146.
157. Taylor, R. C.; Dillin, A. XBP-1 Is a Cell-Nonautonomous Regulator of Stress Resistance and Longevity. Cell, 2013, 153(7), 1435-1447.
158. Rochet, J.-C. Novel therapeutic strategies for the treatment of protein-misfolding diseases. Expert Rev. Mol. Med., 2007, 9(17), 1-34.
159. Chadwick, W.; Mitchell, N.; Martin, B.; Maudsley, S. Therapeutic Targeting of the Endoplasmic Reticulum in Alzheimer's Disease. Curr. Alzheimer. Res., 2012, 9(1), 110-119.
160. Halliday, M.; Mallucci, G. R. Targeting the unfolded protein response in neurodegeneration: A new approach to therapy. Neuropharmacology, 2014, 76, 169-174.
161. Schon, E. A.; Area-Gomez, E. Is Alzheimer's Disease a Disorder of Mitochondria-Associated Membranes? J. Alzheimer's Dis., 2010, 20, S281-S292.
162. Csordas, G.; Renken, C.; Varnai, P.; Walter, L.; Weaver, D.; Buttle, K. F.; Balla, T.; Mannella, C. A.; Hajnoczky, G. Structural and functional features and significance of the physical linkage between ER and mitochondria. J. Cell Biol., 2006, 174(7), 915-921.
163. Hayashi, T.; Rizzuto, R.; Hajnoczky, G.; Su, T. P. MAM: more than just a housekeeper. Trends Cell Biol., 2009, 19(2), 81-88.
164. Szabadkai, G.; Bianchi, K.; Varnai, P.; De Stefani, D.; Wieckowski, M. R.; Cavagna, D.; Nagy, A. I.; Balla, T.; Rizzuto, R. Chaperone-mediated coupling of endoplasmic reticulum and mitochondrial Ca2+ channels. J. Cell Biol., 2006, 175(6), 901-911.
165. Hayashi, T.; Su, T. P. Sigma-1 receptor chaperones at the ERMitochondrion interface regulate Ca2+ signaling and cell survival. Cell, 2007, 131(3), 596-610.
166. de Brito, O. M.; Scorrano, L. Mitofusin 2 tethers endoplasmic reticulum to mitochondria(vol 456, pg 605, 2008). Nature, 2014, 513(7517), 266-266.
167. Poston, C. N.; Krishnan, S. C.; Bazemore-Walker, C. R. In-depth proteomic analysis of mammalian mitochondria-associated membranes(MAM). J. Proteomics, 2013, 79, 219-230.
168. Domingues, S.; Henriques, A. G.; Wu, W. J.; Silva, E.; Silva, O. Altered subcellular distribution of the Alzheimer's amyloid precursor protein under stress conditions. In Signal Transduction Pathways, Pt D: Inflammatory Signaling Pathways and Neuropathology, Diederich, M., Ed. 2007; Vol. 1096, pp 184-195.
169. Katayama, T.; Imaizumi, K.; Sato, N.; Miyoshi, K.; Kudo, T.; Hitomi, J.; Morihara, T.; Yoneda, T.; Gomi, F.; Mori, Y.; Nakano, Y.; Takeda, J.; Tsuda, T.; Itoyama, Y.; Murayama, O.; Takashima, A.; St George-Hyslop, P.; Takeda, M.; Tohyama, M. Presenilin-1 mutations downregulate the signalling pathway of the unfoldedprotein response. Nat. Cell Biol., 1999, 1(8), 479-485.
170. Cali, T.; Ottolini, D.; Brini, M. Mitochondrial Ca(2+) and neurodegeneration. Cell Calcium, 2012, 52(1), 73-85.
171. Cardenas, C.; Miller, R. A.; Smith, I.; Bui, T.; Molgo, J.; Muller, M.; Vais, H.; Cheung, K. H.; Yang, J.; Parker, I.; Thompson, C. B.; Birnbaum, M. J.; Hallows, K. R.; Foskett, J. K. Essential Regulation of Cell Bioenergetics by Constitutive InsP(3) Receptor Ca2+ Transfer to Mitochondria. Cell, 2010, 142(2), 270-283.
172. Doyle, K. M.; Kennedy, D.; Gorman, A. M.; Gupta, S.; Healy, S. J. M.; Samali, A. Unfolded proteins and endoplasmic reticulum stress in neurodegenerative disorders. J. Cell. Mol. Med., 2011, 15(10), 2025-2039.
173. Kraskiewicz, H.; FitzGerald, U. InterfERing with endoplasmic reticulum stress. Trends Pharmacol. Sci., 2012, 33(2), 53-63.
174. Gong, B.; Zhang, L. Y.; Pang, C. P.; Lam, D. S. C.; Yam, G. H. F. Trimethylamine N-oxide alleviates the severe aggregation and ER stress caused by G98R alpha A-crystallin. Mol. Vision, 2009, 15(298-99), 2829-2840.
175. Wu, S. J.; Hsieh, T. J.; Kuo, M. C.; Tsai, M. L.; Tsai, K. L.; Chen, C. H.; Yang, Y. H. Functional regulation of Alu element of human angiotensin-converting enzyme gene in neuron cells. Neurobiol. Aging, 2013, 34(7), 1921. e1-7.
176. Ferreiro, E.; Oliveira, C. R.; Pereira, C. Involvement of endoplasmic reticulum Ca2+ release through ryanodine and inositol 1, 4, 5-triphosphate receptors in the neurotoxic effects induced by the amyloid-beta peptide. J. Neurosci. Res., 2004, 76(6), 872-880.
177. Moreno, J. A.; Halliday, M.; Molloy, C.; Radford, H.; Verity, N.; Axten, J. M.; Ortori, C. A.; Willis, A. E.; Fischer, P. M.; Barrett, D. A.; Mallucci, G. R. Oral Treatment Targeting the Unfolded Protein Response Prevents Neurodegeneration and Clinical Disease in Prion-Infected Mice. Sci. Transl. Med., 2013, 5(206).
178. Ghosh, R.; Wang, L.; Wang, E. S.; Perera, B. G. K.; Igbaria, A.; Morita, S.; Prado, K.; Thamsen, M.; Caswell, D.; Macias, H.; Weiberth, K. F.; Gliedt, M. J.; Alavi, M. V.; Hari, S. B.; Mitra, A. K.; Bhhatarai, B.; Schurer, S. C.; Snapp, E. L.; Gould, D. B.; German, M. S.; Backes, B. J.; Maly, D. J.; Oakes, S. A.; Papa, F. R. Allosteric Inhibition of the IRE1 alpha RNase Preserves Cell Viability and Function during Endoplasmic Reticulum Stress. Cell, 2014, 158(3), 534-548.
179. Lee, G. H.; Lee, H. Y.; Li, B.; Kim, H. R.; Chae, H. J. Bax Inhibitor-1-Mediated Inhibition of Mitochondrial Ca2+ Intake Regulates Mitochondrial Permeability Transition Pore Opening and Cell Death. Sci. Rep., 2014, 4, 5194.
180. Han, S. H.; Mook-Jung, I. Diverse Molecular Targets for Therapeutic Strategies in Alzheimer's Disease. J. Korean Med. Sci., 2014, 29(7), 893-902.
181. Tadic, V.; Prell, T.; Lautenschlaeger, J.; Grosskreutz, J. The ER mitochondria calcium cycle and ER stress response as therapeutic targets in amyotrophic lateral sclerosis. Front. Cell. Neurosci., 2014, 8, 147.
182. Nakajima, A.; Tsuji, M.; Inagaki, M.; Tamura, Y.; Kato, M.; Niiya, A.; Usui, Y.; Oguchi, K. Neuroprotective effects of propofol on ER stress-mediated apoptosis in neuroblastoma SH-SY5Y cells. Eur J Pharmacol, 2014, 725, 47-54.
183. Fülöp, F.; Vígh, L.; Török, Z.; Penke, B.; Horváth, I.; Balogh, G.; Bernáth, S.; Hunya, Á. Heterocyclic compounds with HSP modulating activity Hungarian Patent P1100646, 2012.